Granza Bio grabs $7M seed from Felicis and YC to advance delivery of cancer treatments
Ashwin Nandakumar and Ashwin Jainarayanan were working on their doctorates at adjacent departments in Oxford, but they didn’t know each other. Nandakumar, who was studying oncology, one day stumbled across a curious dataset for prostate cancer, w…